Pharmaceutical Drugs (Statins) Is The Largest Segment Driving The Growth Of Antihyperlipidemic Drugs Market
Antihyperlipidemic Drugs Market The global Antihyperlipidemic Drugs Market is estimated to be valued at US$ 13.6 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Antihyperlipidemic drugs or lipid-lowering drugs help in controlling high cholesterol and reducing triglyceride levels associated with conditions like atherosclerosis, cardiovascular diseases and stroke. These drugs lower lipid levels by inhibiting cholesterol synthesis in the liver or by acting as adsorbents to help remove cholesterol from the body. Market key trends: One of the key trends in the antihyperlipidemic drugs market is the rise in approvals of new drugs by regulatory bodies. In recent years, regulatory authorities like USFDA have approved new additions to antihyperlipidemic drugs owing to a rise in demand from patients and physicians. For instance, in May 2021, USFDA approved a new d...